• Blog
  • Pricing
  • Contact
  • FAQ
Sign InSign Up
AI Agent for Financial MarketsAsk anything. Our AI Agent brings real-time data and full market coverage.Open chat
MarketsStocksCryptoForexCommoditiesCalendarInsiders
ZIOP

ZIOP

ZIOPHARM Oncology, Inc.

NASDAQHealthcareBiotechnologyUS

USD0.87

-0.01 (-0.88%)

Company Profile

CEO

Laurence Cooper

IPO Date

2004-08-20

Sector

Healthcare

Industry

Biotechnology

Exchange

NASDAQ

Country

US

Market Metrics

Open

$0.89

Prev. Close

$0.87

Day Low

$0.86

Day High

$0.97

52W Low

$0.76

52W High

$5.95

Market Cap

$0.21B

Volume

2.13M

OverviewFinancialsRatingsInsidersSentimentsChart Patterns
News SentimentNeutral

Articles

10

Avg Positive

23.3%

Avg Negative

24.7%

Avg Neutral

52.0%

News Feed

Ziopharm Oncology to Report Second Quarter Financial Results on August 9, 2021

GlobeNewsWire·7/26/2021·↑ positive

Ziopharm Oncology to Participate in Upcoming Conferences

GlobeNewsWire·5/24/2021·↑ positive

Ziopharm Oncology Reinforces Clear and Bold Vision for Delivering Value at Annual Shareholders Meeting

GlobeNewsWire
·5/19/2021
·↑ positive

ZIOPHARM Oncology, Inc.'s (ZIOP) Interim CEO Heidi Hagen on Q1 2021 Results - Earnings Call Transcript

Seeking Alpha·5/6/2021·↓ negative

Ziopharm Oncology to Present Poster at American Association for Cancer Research Virtual 2021 Annual Meeting

GlobeNewsWire·4/7/2021·↑ positive

Why Ziopharm Oncology Stock Is Sinking Today

The Motley Fool·3/12/2021·↓ negative

Why Ziopharm Oncology Stock Is Jumping Today

The Motley Fool·2/26/2021·↑ positive

ZIOPHARM Oncology, Inc. (ZIOP) CEO Laurence Cooper on Q4 2020 Results - Earnings Call Transcript

Seeking Alpha·2/25/2021·↓ negative

Ziopharm Oncology to Report Fourth Quarter and Full Year 2020 Financial Results and Host Webcast on February 25, 2021

GlobeNewsWire·2/16/2021·↓ negative

Why Ziopharm Oncology Stock Is Soaring Today

The Motley Fool·2/5/2021·↓ negative